3-Ethoxy-4-fluorobenzaldehyde → N-[1-(3-Ethoxy-4-fluoro-benzyl)piperidin-4-yl]-5-methyl-nicotinamide
Reaktionsgleichung
[CH3:1][C:2]1[CH:3]=[N:4][CH:5]=[C:6]([CH:16]=1)[C:7]([NH:9][CH:10]1[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]1)=[O:8].[CH2:17]([O:19][C:20]1[CH:21]=[C:22]([CH:25]=[CH:26][C:27]=1[F:28])[CH:23]=O)[CH3:18]>>[CH2:17]([O:19][C:20]1[CH:21]=[C:22]([CH:25]=[CH:26][C:27]=1[F:28])[CH2:23][N:13]1[CH2:12][CH2:11][CH:10]([NH:9][C:7](=[O:8])[C:6]2[CH:16]=[C:2]([CH3:1])[CH:3]=[N:4][CH:5]=2)[CH2:15][CH2:14]1)[CH3:18]Komponenten
3
Versuchsvorschrift
The title compound (11 mg, 30%) was prepared analogously to example 30 from 5-methyl-N-(piperidin-4-yl)-nicotinamide and 3-ethoxy-4-fluoro-benzaldehyde. MS: 372.5 (MH+)
Quellen und Nachweise
- ORD-Eintrag
- ord-8ee9093384594696a4dd11d02ce8b963
- Quelldatensatz
- uspto-grants-2010_08